» Articles » PMID: 10817261

Human Bone Cell Cultures in Biocompatibility Testing. Part II: Effect of Ascorbic Acid, Beta-glycerophosphate and Dexamethasone on Osteoblastic Differentiation

Overview
Journal Biomaterials
Date 2000 May 19
PMID 10817261
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

This work analyses the proliferation/differentiation behaviour of human bone marrow cells cultured in alpha-minimum essential medium supplemented with 10% foetal bovine serum (standard medium) and in the presence of ascorbic acid (AA, 50 microg ml(-1)), beta-glycerophosphate (betaGP, 10 mmol) and dexamethasone (Dex, 10 nmol) under selected experimental conditions. Cultures were compared concerning cell morphology, cell growth, ALP activity and ability to form calcium phosphate deposits. Cells growing in the various experimental conditions proliferated gradually with the incubation time and presented high ALP activity. Cultures grown in standard medium and in the presence of either AA or Dex failed to form calcium phosphate deposits. Cultures grown in the presence of betaGP, betaGP + AA and betaGP + AA + Dex, i.e. in the presence of a source of phosphate ions, showed the formation of a mineralised extracellular matrix. The presence of Dex resulted in a significant induction in the ALP activity and ability to form mineral deposits. The behaviour of the various cell cultures is in agreement with previous studies stating a reciprocal and functionally coupled relationship between proliferation and differentiation, i.e. cultures grown in a medium containing betaGP presented a less proliferative but more differentiated osteoblastic cell population, as compared to cultures lacking the mineralisation process.

Citing Articles

Functionalization of PCL-Based Fiber Scaffolds with Different Sources of Calcium and Phosphate and Odontogenic Potential on Human Dental Pulp Cells.

Anselmi C, Soares I, Mota R, Leite M, de Oliveira Ribeiro R, Fernandes L J Funct Biomater. 2024; 15(4).

PMID: 38667554 PMC: 11051160. DOI: 10.3390/jfb15040097.


Osteogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells on Composite Polymeric Scaffolds: A Review.

Hemati S, Ghiasi M, Salimi A Curr Stem Cell Res Ther. 2024; 20(1):33-49.

PMID: 38315659 DOI: 10.2174/011574888X263333231218065453.


Unveiling the Osteogenic Potential of Tetracyclines: A Comparative Study in Human Mesenchymal Stem Cells.

Martin V, Francisca Bettencourt A, Santos C, Fernandes M, Gomes P Cells. 2023; 12(18).

PMID: 37759467 PMC: 10526833. DOI: 10.3390/cells12182244.


Exosomes derived from bone marrow mesenchymal stem cells regulate pyroptosis via the miR-143-3p/myeloid differentiation factor 88 axis to ameliorate intestinal ischemia-reperfusion injury.

Wan Z, Zhang Y, Lv J, Yuan Y, Guo W, Leng Y Bioengineered. 2023; 14(1):2253414.

PMID: 37674357 PMC: 10486297. DOI: 10.1080/21655979.2023.2253414.


Differing responses of osteogenic cell lines to β-glycerophosphate.

Yevlashevskaya O, Scheven B, Walmsley A, Shelton R Sci Rep. 2023; 13(1):14472.

PMID: 37660110 PMC: 10475023. DOI: 10.1038/s41598-023-40835-w.